Onychomycosis: Evaluation, Treatment Options, Managing Recurrence, and Patient Outcomes

Tracey C Vlahovic

doi:10.1016/j.cpm.2016.02.001

Onychomycosis: Evaluation, Treatment Options, Managing Recurrence, and Patient Outcomes

Clin Podiatr Med Surg. 2016 Jul;33(3):305-18. doi: 10.1016/j.cpm.2016.02.001. Epub 2016 Mar 26.

Author

Tracey C Vlahovic¹

Affiliation

¹ Department of Podiatric Medicine, Temple University School of Podiatric Medicine, 148 North 8th Street, Philadelphia, PA 19107, USA. Electronic address: traceyv@temple.edu.

PMID: 27215153
DOI: 10.1016/j.cpm.2016.02.001

Abstract

Onychomycosis is the most common nail disease seen in podiatric practice. Effective long-term management remains problematic. We need to treat onychomycosis effectively to prevent its progression into a severe, debilitating, and painful condition, and to manage recurrence. With new agents now available and greater discussion on management strategies, this article reviews the appropriate evaluation of the disease, treatment options, and optimal patient outcomes.

Keywords: Efinaconazole; Laser; Mycosis; Onychomycosis; Tavaborole; Tinea pedis; Toenail; Trichophyton rubrum.

Publication types

Review

MeSH terms

Foot Dermatoses / diagnosis*
Foot Dermatoses / etiology
Foot Dermatoses / therapy*
Humans
Onychomycosis / diagnosis*
Onychomycosis / etiology
Onychomycosis / therapy*
Recurrence
Treatment Outcome